poil-1 schreef op 16 april 2020 08:59:
Montpellier, April 16th 2020 – 08h30 AM CEST
New version of the COVID-19 protocol
Intrasense (FR0011179886 - ALINS), a specialist in medical imaging software
solutions and designer of Myrian, continues its involvement in the fight against
COVID-19 and announces the availability on Friday April 17th, 2020 of a second
version of its scanner reading protocol dedicated to the epidemic.
A new version authorized by the FDA and in the process of CE
marking
A new milestone has been reached for this new application, which is authorized
by the FDA in the United-States, and should receive its CE marking for Europe in
the next few days. These authorizations place the new version of the protocol in
the category of medical devices, which can therefore be used in an even broader
clinical context, from screening to diagnosis and large-scale therapeutic trials to
find an effective treatment against the virus.
An application benefiting from numerous high-level
collaborations
With more than 280 licenses requests since the start of the operation, the
company has benefited from numerous positive feedbacks and requests for
evolution and collaboration on this new protocol, in France and abroad. Thanks
to the flexibility of the Myrian platform and the Myrian Studio approach, the new
dedicated COVID-19 protocol has been developed in a few weeks and the
improvements taken into account in a few days demonstrate the company's
ability to be extremely agile when faced with new needs.
Nicolas Reymond, CEO of Intrasense, explains: “We are proud of what has been
accomplished in such a short time by our teams and I would like to warmly thank
all the radiologists who helped us build this new version, especially in France
and in Italy. Without them it would not have been possible. "